In a C57BL/6 mouse model of atherosclerosis, the absence of sortilin induced a defect of IL-6 and IFN-γ secretion in activated macrophages and Th1 cells, reducing the inflammatory component of vascular lesions and atherosclerosis, independently of sortilin effect on lipid metabolism. This evidence concerns the gene IL6 and atherosclerosis.